PRRT2 c.856G>C ;(p.V286L)

Variant ID: 16-29825231-G-C

NM_145239.2(PRRT2):c.856G>C;(p.V286L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: PRRT2: V286L
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.

Current Neuropharmacology
Liu, Wuyi W; Li, Ming D MD
Publication Date: 2018

Variant appearance in text: PKC: V286L
PubMed Link: 28762314
Variant Present in the following documents:
  • Main text
  • CN-16-350.pdf
View BVdb publication page